Bob Bradway, Amgen CEO (Justin Kase Conder/AP Images for Amgen)

Am­gen cites in­fla­tion, pres­sure on drug prices in 450-per­son lay­off

Am­gen is lay­ing off about 450 work­ers, the com­pa­ny told End­points News, just two months af­ter let­ting go 300 staffers.

A spokesper­son said the lay­offs im­pact less than 2% of the Cal­i­for­nia bio­phar­ma’s to­tal head­count, which was about 24,000 work­ers, per a JP Mor­gan Health­care Con­fer­ence pre­sen­ta­tion in Jan­u­ary.

“We made these changes to re­align our ex­pense base in the face of in­ten­si­fy­ing pres­sure on drug prices and high lev­els of in­fla­tion so that we can con­tin­ue to de­liv­er val­ue for our pa­tients, staff and share­hold­ers,” the spokesper­son said in an emailed state­ment to End­points Thurs­day af­ter the mar­kets closed, not­ing the af­fect­ed peo­ple will be of­fered sev­er­ance and tran­si­tion ser­vices.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.